Literature DB >> 6756

Effect of blockade of 5-hydroxytryptamine re-uptake on drug-induced antinociception in the rat.

M F Sugrue, I McIndewar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 6756     DOI： 10.1111/j.2042-7158.1976.tb04652.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  8 in total

1.  The effects of morphine on the accumulation of homovanillic and 5-hydroxyindoleacetic acids in the choroid plexus of rats.

Authors:  J T Huang; I J Wajda
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

2.  Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors.

Authors:  D T Wong; L R Reid; F P Bymaster; P G Threlkeld
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

3.  Antagonism of fenfluramine-induced hyperthermia in rats by some, but not all, selective inhibitors of 5-hydroxytryptamine uptake.

Authors:  M F Sugrue
Journal:  Br J Pharmacol       Date:  1984-04       Impact factor: 8.739

4.  Involvement of 5-hydroxytryptamine in the analgesic action of pethidine and morphine in mice.

Authors:  R Botting; A Morinan
Journal:  Br J Pharmacol       Date:  1982-04       Impact factor: 8.739

5.  Attenuation of pethidine-induced antinociception by zimelidine, an inhibitor of 5-hydroxytryptamine reuptake.

Authors:  G F Gebhart; S A Lorens
Journal:  Br J Pharmacol       Date:  1980-11       Impact factor: 8.739

6.  Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia.

Authors:  S O Ogren; A C Holm
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

7.  On the role of 5-hydroxytryptamine in drug-induced antinociception.

Authors:  M F Sugrue
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

Review 8.  Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.

Authors:  P Benfield; R C Heel; S P Lewis
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.